» Articles » PMID: 39056768

Advancements in Utilizing Natural Compounds for Modulating Autophagy in Liver Cancer: Molecular Mechanisms and Therapeutic Targets

Abstract

Autophagy, an intrinsic catabolic mechanism that eliminates misfolded proteins, dysfunctional organelles, and lipid droplets, plays a vital function in energy balance and cytoplasmic quality control, in addition to maintaining cellular homeostasis. Liver cancer such as hepatocellular carcinoma (HCC) is one of the most common causes of cancer deaths globally and shows resistance to several anticancer drugs. Despite the rising incidence and poor prognosis of malignant HCC, the underlying molecular mechanisms driving this aggressive cancer remain unclear. Several natural compounds, such as phytochemicals of dietary and non-dietary origin, affect hepatocarcinogenesis signaling pathways in vitro and in vivo, which may help prevent and treat HCC cells. Current HCC cells treatments include chemotherapy, radiation, and surgery. However, these standard therapies have substantial side effects, and combination therapy enhances side effects for an acceptable therapeutic benefit. Therefore, there is a need to develop treatment strategies for HCC cells that are more efficacious and have fewer adverse effects. Multiple genetic and epigenetic factors are responsible for the HCC cells to become resistant to standard treatment. Autophagy contributes to maintain cellular homeostasis, which activates autophagy for biosynthesis and mitochondrial regulation and recycling. Therefore, modifying autophagic signaling would present a promising opportunity to identify novel therapies to treat HCC cells resistant to current standard treatments. This comprehensive review illustrates how natural compounds demonstrate their anti-hepatocellular carcinoma function through autophagy.

Citing Articles

Integrating alternative therapies in overcoming chemotherapy resistance in tumors.

Alqarni S, Khan N Mol Biol Rep. 2025; 52(1):239.

PMID: 39961936 DOI: 10.1007/s11033-025-10361-1.

References
1.
Patel K, Brown V, Jones D, Britton R, Hemingway D, Miller A . Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010; 70(19):7392-9. PMC: 2948608. DOI: 10.1158/0008-5472.CAN-10-2027. View

2.
Shakoor H, Feehan J, Apostolopoulos V, Platat C, Al Dhaheri A, Ali H . Immunomodulatory Effects of Dietary Polyphenols. Nutrients. 2021; 13(3). PMC: 7996139. DOI: 10.3390/nu13030728. View

3.
Mansouri K, Rasoulpoor S, Daneshkhah A, Abolfathi S, Salari N, Mohammadi M . Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer. 2020; 20(1):791. PMC: 7446227. DOI: 10.1186/s12885-020-07256-8. View

4.
Park M, Rahman M, Rahman M, Kim J, Choi M, Kim J . Potential Therapeutic Implication of Herbal Medicine in Mitochondria-Mediated Oxidative Stress-Related Liver Diseases. Antioxidants (Basel). 2022; 11(10). PMC: 9598588. DOI: 10.3390/antiox11102041. View

5.
Du Y, Al Mamun A, Lyu A, Zhang H . Natural Compounds Targeting the Autophagy Pathway in the Treatment of Colorectal Cancer. Int J Mol Sci. 2023; 24(8). PMC: 10138367. DOI: 10.3390/ijms24087310. View